Medistim — Earnings Release 2009

Feb 25, 2010

Fourth quarter and preliminary result for 2009 for MediStim ASA

MediStim had a 72 % growth in profit before tax for

the year 2009 to MNOK 37.2. The company's new

product, VeriQC, the new ultrasound imaging product,

was introduced in Europe in fourth quarter and the 5

first systems were sold after the introduction. All

the filing for VeriQC in Japan was done in 2009 and

the company received the necessary approval for

VeriQC in January 2010.

The Board suggests a dividend of NOK 0.90 per share

where NOK 0.15 is extraordinary dividend related to

MediStims 25 year anniversary. The Board also

suggests amortization of 523.989 of own shares.